Nursing management of Myasthenia Gravis

Slides:



Advertisements
Similar presentations
Neurological Diseases Jerry Carley RN, MSN, MA, CNE
Advertisements

FACULTY OF MEDICINE PHYSIOLOGY DEPARTMENT DR. NERMEN MADY DR. RAMEZ.
Nursing Care of Clients with Upper Respiratory Disorders.
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 15 Cholinesterase Inhibitors and Their Use in Myasthenia Gravis.
Myasthenia Gravis Dr. Belal M. Hijji, RN. PhD February 29, 2012.
Muscle weakness Index case Year 1 Michaelmas Term.
Guillain-Barré Syndrome, Myasthenia Gravis,
Terri Kueber, CRNA, MS. Explain the pathophysiology and classification of Myasthenia Gravis (MG) List the signs and symptoms and clinical manifestation.
MYASTHENIA GRAVIS Roziah Saeh ( ) Jarina Jamaluddin ( ) Juliana Shariff ( ) Nurshahirah Ahmad ( ) Nik Hasni (2010.
Agents Used to Treat Musculoskeletal Health Alterations.
 Myasthenia gravis is a chronic autoimmune neuromuscular disease that is characterized by different degrees of weakness of the skeletal muscles of the.
Neuromuscular Disorders Guillain-Barré Syndrome - Chapter 30 Myasthenia Gravis – Chapter 31.
1 Review of Musculoskeletal System Chapter Muscle Skeletal muscle > 600 muscles in body Fascia –Epimysium – forms tendons at ends –Perimysium –
Management of Patients With Chronic Pulmonary Disease.
Medical-Surgical Nursing: An Integrated Approach, 2E Chapter 22 NURSING CARE OF THE CLIENT: IMMUNE SYSTEM.
GENERAL THORACIC SURGERY CHAPTER 168
Guillain-Barré Syndrome Miss Fatima Hirzallah Guillain-Barré syndrome is an autoimmune attack on the peripheral nerve myelin. The result is acute, rapid.
Myasthenia Gravis.  Describe myasthenia gravis  Signs and Symptoms of the disease  Describe the treatments available Purpose and Objectives.
Chapter 46 Care of Patients with Problems of the Peripheral Nervous System Mrs. Marion Kreisel MSN, RN NU230 Adult Health 2 Fall 2011.
MYASTHENIA GRAVIS (MG)
Sophia M. Chung, M.D. Depts of Ophthalmology &
This lecture was conducted during the Nephrology Unit Grand Ground by Medical Student rotated under Nephrology Division under the supervision and administration.
An autoimmune neurologic disorder
Myasthenia Gravis Victor Politi,M.D.
MYASTHENIA GRAVIS ANESTHESIOLOGY Jasdeep Dhaliwal Clinical Rotation.
Linda S. Williams / Paula D. Hopper Copyright © F.A. Davis Company Understanding Medical Surgical Nursing, 4th Edition Chapter 50 Nursing Care of.
Interference with Ventilation Oxygen Therapy Indications: Indications: Treat: Respiratory; CV; CNS disturbances Treat: Respiratory; CV; CNS disturbances.
Adult Medical-Surgical Nursing Neurology Module: Multiple Sclerosis.
Adult Medical-Surgical Nursing Neurology Module: Parkinson’s Disease.
© 1999 Lockheed Martin Energy Research Corporation CA128 NERVE AGENT EXPOSURE.
Guillain-Barre’ Syndrome
MS مولتیپل اسکلروزیس. Client with Multiple Sclerosis Description Chronic demyelinating disease of CNS associated with - abnormal immune response to environmental.
Copyright © 2011 Delmar, Cengage Learning. ALL RIGHTS RESERVED. Chapter 32 Oxygenation.
Pre-Operative and Post-Operative Care
Myasthenia Gravis.
Copyright © 2013, 2010, 2006, 2002 by Saunders, an imprint of Elsevier Inc.
Neurology Chapter of IAP
MYASTHENIA GRAVIS Aswad H. Al.Obeidy FICMS, FICMS GE&Hep Kirkuk General Hospital.
F.Ahmadabadi MD Child Neurologist July 2015 ARUMS Guillain-Barre syndrome & Myasthenia Gravis.
MYASTHENIA GRAVIS “FROM WEAKNESS SHALL COME STRENGTH”. BY PATTI HAMILTON.
Kaitlyn Bradshaw. Is a rapid pain under any voluntary muscle DESCRIPTION.
Justine Gonzalez Azusa Pacific University, School of Nursing GNRS 584 Mental Health Nursing.
Assessment and Treatments  History: weakness caused by any precipitating factors ( i.e. infection, emotional upset)  Time of weakness: after repeated.
Copyright © 2006 by Mosby, Inc. Slide 1 Chapter 30 Myasthenia Gravis Figure Myasthenia gravis. Inset, Atelectasis, a common secondary anatomic alteration.
Autonomic Nervous System (ANS) Cholinergic Drugs 4 أ0م0د.وحدة بشير اليوزبكي.
Multiple Sclerosis. Multiple sclerosis (MS) is a disease that affects central nervous system (brain and spinal cord). It damages the myelin sheath. 
NURSING MANAGEMENT OF COPD. Physiology  Respiratory System Upper Tract & Lower Tract  Goal is to transfer oxygen and carbon dioxide.
Nursing management of Multiple sclerosis
Nursing management of Increased Intracranial pressure
Myasthenia Gravis.
Nursing management of Acute Kidney Injury
JUDITH M. WILKINSON LESLIE S. TREAS KAREN BARNETT MABLE H. SMITH FUNDAMENTALS OF NURSING Copyright © 2016 F.A. Davis Company Chapter 36: Oxygenation.
( Relates to Chapter 22, “Nursing Management: Visual and Auditory Problems,” in the textbook) Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier.
Nursing Care of Patients with Peripheral Nervous System Disorders.
Understanding Medical Surgical Nursing, 4th Edition CHAPTER 50 Nursing Care of Patients with Peripheral Nervous System Disorders.
Diseases: PARKINSON’S AND MYASTHENIA GRAVIS Jane E. Binetti RN MSN
Jennifer Vilarino Period: 5
Neuromuscular disorders
Chapter 35 Immobility.
Manage a Neurological Mystery
Myasthenia Gravis Johan Perrand Period 3.
Bronchial Asthma.
“Grave Muscle Weakness”
Chapter 25 Respiratory Care Modalities
Major Hormone Secreting Glands of the Endocrine System
Multiple Sclerosis.
Myasthenia Gravis By: Cheryl Hamilton.
Presentation transcript:

Nursing management of Myasthenia Gravis Today’s topic is Nursing Management for clients with myasthenia gravis.

Pathophysiology – Myasthenia Gravis (MG) A chronic progressive disorder of the peripheral nervous system affecting transmission of nerve impulses to voluntary muscles Etiology: unknown An autoimmune process triggers formation of autoantibodies that decrease number of acetylcholine receptors and widen gap between axon ending and muscle fiber in neuromuscular junction

Pathophysiology Muscle contraction is hindered because IgG autoantibodies prevent acetylcholine from binding with receptors at neuromuscular junction Onset is slow precipitated by emotional stress, hormonal disturbance (pregnancy, thyroid disturbance), infection/vaccination, trauma, surgery, temp extremes, excessive exercise

Etiology Associated with continued production of autoantibodies by thymus gland in 75% of cases family history of autoimmune disorders are implicated

Clinical Manifestations Muscle weakness Double vision (diplopia) weak eyelids (unilateral ptosis) Difficulty speaking or smiling Difficulty chewing and swallowing

Specific clinical manifestations

Assessment of Labs/Diagnostics Arterial Blood Gas & Pulmonary function tests For respiratory compromise Electromyography (EMG) Decreased amplitude when motor neurons are stimulated Confirming diagnosis IV administration of edrophonium chloride (Tensilon) Allows acetylcholine to bind with its receptors and temporarily improves symptoms Weakness returns after effects of Tensilon are discontinued

Problems with MG Ineffective airway clearance Impaired verbal communication Activity intolerance

Interventions Focuses on medication management with anticholinesterases neostigmine (Prostigmin) pyridostigmine (Mestinon) Immunosuppressant corticosteroids, azathioprine (Imuran), and cyclosporine (Neoral) Anti-inflammatory medications Thymectomy Plasmapheresis Removes IgG (antiacetylcholine) antibodies Atropine sulfate for cholinergic crisis

Interventions Maintain effective breathing pattern and airway clearance Assess for respiratory distress Monitor meals and teach client to bend head slightly forward while eating and drinking to improve swallowing Teach client to avoid exposure to infections Teach client to effectively coughing, use chest physiotherapy and incentive spirometry Provide adequate nutrition Schedule meds 30-45 minutes before eating for peak muscle strength Offer food frequently in small amounts that are easy to chew and swallow (soft or semisolid) Promote improved physical mobility with referrals to physical therapy and/or occupational therapy Provide eye care: instill artificial tears; use a patch over one eye for double vision; wear sunglasses to protect eyes from bright lights

Client education Take medication on time and keep prescriptions filled Plan rest periods and conserve energy, plan major activities early in day, schedule activities during peak medication effect Avoid extremes of hot and cold, exposure to infections, emotional stress and meds that may worsen or precipitate an exacerbation (alcohol, sedatives, and local anesthetics) Recognize and report signs of crises Use alternative methods of communication if needed

Evaluation: Desired Outcomes Maintain Muscle function Minimize side effects of medications Minimize complications of MG (myasthenic or cholinergic crises) Maintain quality of life

Comparison of myasthenia and cholinergic crises Myasthenia Crisis Cholinergic Crisis Failure to take medication as prescribed or medication too low Over dose of anticholinesterase medications resulting in increased Acetylcholine at the receptor sites

Evaluation Maintain optimal muscle function Be free from side effects of medications Client maintains patent airway and breathing without aspiration Maintain activities of daily living with assistance Demonstrates adequate coping skills for managing chronic and debilitating illness

References Rangel-Castillo, L, Gopinath, S., & Robertson, C.S. (2009). Management of intracranial hypertension. Neurologic Clinics, 26(2), 521-541. Ignatavicius, D. D. & Workman, M. L. (2010). Medical-surgical nursing: patient-centered collaborative care (6th ed.). St. Louis, MO: Saunders Elsevier. Lewis, S. L., Heitkemper, M. M., Dirksen, S. R., & Bucher, L. (2014). Medical-surgical nursing: Assessment & management of client problems (9th ed.). St. Louis, MO: Mosby Hogan, M., Dentlinger, N.C., & Ramdin, V. (2014). Medical- surgical: nursing pearson nursing reviews and rationales (3rd ed.). Boston, MA: Pearson.